Lungpacer Medical

Lungpacer Medical’s AeroPace System Under FDA Review: A Potential Game-Changer for Ventilated Patients

EXTON, PA — Lungpacer Medical has announced that its innovative AeroPace System is currently under review by the Food and Drug Administration (FDA) as part of a premarket approval (PMA) application. …

Lungpacer Medical’s AeroPace System Under FDA Review: A Potential Game-Changer for Ventilated Patients Read More

Philips’ DreamStation 2 CPAP Machines

FDA Issues Safety Alert on Philips Respironics’ DreamStation 2 CPAP Machines Due to Overheating Risks

The U.S. Food and Drug Administration (FDA) has recently issued an alert for patients and healthcare providers regarding a safety issue involving the DreamStation 2 Continuous Positive Airway Pressure (CPAP) …

FDA Issues Safety Alert on Philips Respironics’ DreamStation 2 CPAP Machines Due to Overheating Risks Read More